基本信息
浏览量:42
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
My primary focus is the optimization of drug therapy using quantitative models of drug disposition (pharmacokinetics) and action (pharmacodynamics), including physiologically based pharmacokinetic models, to integrate in vitro and in vivo data, leading to better understanding of drug disposition and effect. Patient-specific variables including demographic and pharmacogenetic factors are incorporated into the models to identify individuals most likely to respond to drug therapy or who are at most risk of experiencing an adverse event. Also use physiologically-based pharmacokinetic models to examine changes in drug metabolism and disposition in various populations, including pregnant women and children.
研究兴趣
论文共 166 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancerno. 10 (2024): 1858-1868
Maxime Le Merdy,Ke Xu Szeto, Jeremy Perrier,Michael B. Bolger,Viera Lukacova, Karel Allegaert,Sara Quinney,Andre Dallmann
PHARMACEUTICSno. 1 (2024): 96
American Journal of Obstetrics & Gynecology MFMno. 3 (2024): 101304-101304
CLINICAL PHARMACOLOGY & THERAPEUTICS (2024): S106-S106
引用0浏览0引用
0
0
Silpa Gampala,Hye-ran Moon,Randall Wireman, Jacqueline Peil, Sonia Kiran,Dana K. Mitchell,Kylee Brewster,Henry Mang,Andi Masters,Christine Bach, Whitney Smith-Kinnamen,Emma H. Doud,
PHARMACOLOGICAL RESEARCH (2024)
CLINICAL PHARMACOLOGY & THERAPEUTICS (2024): S105-S106
引用0浏览0引用
0
0
M. Kandasamy, T. Richardson, A. Masters, C. Bach, S. Sukoff Rizzo,S. Doolen,S. Quinney, C. Jesudason
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023): S51-S51
引用0浏览0引用
0
0
Proceedings of IMPRSno. 1 (2023)
加载更多
作者统计
#Papers: 167
#Citation: 2094
H-Index: 24
G-Index: 43
Sociability: 6
Diversity: 3
Activity: 42
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn